Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
$1.52+0.09 (+6.29%)
Close on Nov 17, 2026Market cap $72.03MP/E –Yield –
Zhengye Biotechnology r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was CN¥18.01M, up 40.8% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CN¥18.01M | +40.8% |
| FY2024 | Dec 31, 2024 | CN¥12.79M | +7.5% |
| FY2023 | Dec 31, 2023 | CN¥11.90M | -11.3% |
| FY2022 | Dec 31, 2022 | CN¥13.42M | – |
See a number that looks wrong?